Member Log in

Not a member? Register here

Log in with Facebook

*

News

Autifony Therapeu...

Autifony Therapeutics announces start of Phase IIa study for first-in-class drug to treat tinnitus

Autifony Therapeutics announces start of Phase IIa study for first-in-class drug to treat tinnitus

More
BTA to benefit fr...

BTA to benefit from "FlipSide" of famous DJs

FlipSide will help raise awareness of tinnitus and funds for the British Tinnitus Association.

More
BTA launch new co...

BTA launch new course: Assessment and management of tinnitus in children

The BTA are pleased to announce that they will be facilitating a new course in 2015 covering the assessment and management of children with tinni...

More
Small Research Pr...

Small Research Project Commissioning

The British Tinnitus Association (BTA) encourages research in tinnitus, by commissioning small research projects for up to £5,000 to conduct feas...

More
Exciting opportun...

Exciting opportunity to join the BTA team

The BTA has an exciting new opportunity for a Volunteering and Engagement Officer to join our team.

More
Autifony awarded ...

Autifony awarded £2.2m to progress drug trial for tinnitus

Autifony Therapeutics Limited, who are pioneering the development of drug treatments for hearing disorders has announced that it has been awarded...

More

Events

View the calendar